Kalaris Therapeutics, Inc. (NASDAQ:KLRS) has 51 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -1,925 | -4.77% | $0.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 0 | 1,300,000 | 0.00% | $0.00 |
| Samsara BioCapital, LLC | 31 Dec, 2025 | 0 | 1,500,000 | 13.10% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 6,065 | 0.00% | $0.00 |
| Alyeska Investment Group, L.P. | 31 Dec, 2025 | 0 | 403,551 | 0.00% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | 700,000 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 89,739 | 44.20% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 117,534 | 36.93% | $0.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 92,261 | 0.00% | $0.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 0 | 360,000 | 0.00% | $0.00 |
| Raymond James Financial Inc | 31 Dec, 2025 | 0 | 88,436 | 0.00% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 200,000 | 0.00% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | -25,000 | -22.17% | $0.00 |
| Kalehua Capital Management LLC | 31 Dec, 2025 | 0 | 139,901 | 0.00% | $0.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | -141,102 | -58.52% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 18,096 | 28.03% | $0.00 |
| WHI TRUST Co LLC | 31 Dec, 2025 | 0 | 97,493 | 0.00% | $0.00 |
| 683 Capital Management, LLC | 31 Dec, 2025 | 0 | 80,590 | 0.00% | $0.00 |
| Propel Bio Management, LLC | 31 Dec, 2025 | 0 | 42,053 | 0.00% | $0.00 |